About
Prof. Rob Henning is a Professor of Pharmacology at the University of Groningen, affiliated with the Faculty of Medical Sciences and the Department of Pharmacology. His research focuses on hibernation biology, cardiovascular systems, and neurodegenerative diseases, particularly leveraging insights from hibernation to develop novel therapies. He leads projects such as 'The cool brain: How hibernators maintain neuronal integrity' and 'Increased lifespan in hibernators despite DNA damage.'
- Member of the Certification Board of the Dutch Society of Pharmacology
- Member of the Scientific Advisory Board of Sulfateq BV
- Organizer of the 16th International Hibernation Symposium
His work includes developing compounds like SUL-138, targeting mitochondria to address Alzheimer’s disease and other metabolic disorders. He actively engages in media discussions about hibernation's potential applications for human health, including space travel and medical advancements.
